about
Old and new: recent innovations in vaccine biology and skin T cellsAnnulling a dangerous liaison: vaccination strategies against AIDS and tuberculosisAntibody response after single H1N1 influenza vaccine in chronic dialysis patients.Model-based design of growth-attenuated virusesAntibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particlesBursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickensThe efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors.DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Novel antigen delivery technologies: a review.Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvantsAdjuvant effects mediated by the carbohydrate recognition domain of Agrocybe aegerita lectin interacting with avian influenza H9N2 viral surface glycosylated proteins.Proteome analysis of Duck Tembusu virus (DTMUV)-infected BHK-21 cells.Implications of decoupling the intracellular and extracellular levels in multi-level models of virus growth.In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model.Effects of recombinant Agrocybe aegerita lectin as an immunoadjuvant on immune responses.
P2860
Q27013570-8755552B-2366-4FFD-9A20-A038C2C088C5Q28243702-EAF73C10-27B5-4A1F-80A9-FFDB217F4D29Q30426760-0456F0D6-E876-48A3-9151-67F36A293FCFQ33256104-0B92D937-3703-416D-82A0-AFFAAEF0185CQ33649920-F8C15647-001B-42BF-958B-8C90052531D4Q35191166-95136036-6211-4379-BF39-3AC639C72545Q35828417-60EF7FE1-8064-47CF-A27F-AA1F4BC896A9Q36491901-0E65FC24-9FF4-44EB-B20A-932CC71AD7BEQ36498186-FFE96999-FE0A-4C80-8F7D-E975F42F0374Q38383368-9CDD9610-3088-4017-9E17-F549A1733BE8Q39538202-3671AE1B-791D-446C-9AA0-992B7D0AE51DQ40083668-24F0BFDE-408A-4335-ACB2-B7702711755CQ40197343-1682C32E-3624-4FCE-B3F4-4F8BB0B23112Q42986808-61AE2EAF-1A4D-4263-A442-C9A163044957Q42991283-BD23F633-C6F7-4C6C-9D67-682D3637F772Q47598017-F70175E0-8401-49FA-B972-E25CD9169A91
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Vaccine developments.
@en
Vaccine developments.
@nl
type
label
Vaccine developments.
@en
Vaccine developments.
@nl
prefLabel
Vaccine developments.
@en
Vaccine developments.
@nl
P2860
P356
P1433
P1476
Vaccine developments.
@en
P2093
P2860
P2888
P304
P356
10.1038/NM0598SUPP-515
P407
P433
P577
1998-05-01T00:00:00Z
P5875
P6179
1049253237